O
BIVV

OppenheimerFunds’s Bioverativ Inc. Common Stock BIVV Stock Holding History

OppenheimerFunds’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,434,200
Closed -$77.3M – 1870
2017
Q4 		$77.3M Buy
1,434,200
+853,853
+147% +$46.7M 0.09% 226
2017
Q3 		$33.1M Buy
580,347
+575,856
+12,822% +$33.7M 0.04% 415
2017
Q2 		$270K Sell
4,491
-159,782
-97% -$9.1M ﹤0.01% 1737
2017
Q1 		$8.95M Buy
+164,273
New +$8.09M 0.01% 779

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

OppenheimerFunds's BIVV Position: Q1 2018 in Review

OppenheimerFunds sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,434,200 shares — an estimated $77.3M sold.

OppenheimerFunds first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $77.3M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • OppenheimerFunds reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • OppenheimerFunds sold 1,434,200 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $77.3M.
  • OppenheimerFunds first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • OppenheimerFunds's Bioverativ Inc. Common Stock position peaked at $77.3M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.